Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CALT will decline by -0.16% over the next 2 Weeks and hit $39.94 by Friday, October 11, 2024. In that time frame, CALT's share price is expected to range between $39.41 and $40.43.
BearishAverageBullishCALT shares fell -0.10% in Friday, September 20, 2024's trading session, dropping from a previous close of $40.04 to move at $40.00. The stock demonstrated notable intraday movement (see CALT's key stats for a full breakdown), fluctuating between $40.00 and $43.00, a +7.50% trading range. While recent weeks have seen some volatility, CALT has managed to secure a -1.84% drop over the past 2 weeks. The downward price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.
Will CALT Continue Its Upward Trend?
According to analyst ratings and projections for CALT, Calliditas Therapeutics AB (publ) shares are anticipated to increase by +1.53%, potentially reaching $40.62 per share by October 11, 2024. Short-term technical indicators currently suggest a neutral sentiment for CALT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CALT stock forecast, now is a good time to buy CALT stock because its current trading price is -0.05% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CALT covering social and institutional perspectives.
CALT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CALT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.02% to 53.26%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 59.47%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 58.87%, maintains a neutral outlook for the long term. Insights into CALT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Calliditas Therapeutics AB (publ) Monthly Forecast 2024–2025
September 2024
According to our latest forecast models, Calliditas Therapeutics AB (publ) (CALT) is positioned to show a strong performance in September 2024. The price is predicted to move between $19.78 and $24.28, settling at an average of $22.28. This could translate to a -44.30% loss.
October 2024
Based on current market signals, Calliditas Therapeutics AB (publ) is projected to trend october 2024. We forecast a trading range from $17.52 to $31.20, with a likely average price of $24.07. Investors could expect a potential return of -39.83%.
November 2024
Our predictive algorithms indicate Calliditas Therapeutics AB (publ) stock may see a shift in November 2024. The expected range spans $24.38–$32.88, with an average target of $29.02. This represents a cautious outlook and a possible loss of -27.45%.
December 2024
Analyzing established trends, Calliditas Therapeutics AB (publ) looks set to move in December 2024. Projections place the stock between $24.91 and $32.01, averaging around $28.53. This suggests a -28.68% loss from current levels.
January 2025
Market indicators suggest Calliditas Therapeutics AB (publ) could experience notable changes during January 2025. Prices could fluctuate within $24.48 to $30.74, with a midpoint forecast of $27.51. The stock might deliver a -31.23% loss.
February 2025
Forecasting for February 2025, models estimate that Calliditas Therapeutics AB (publ) may undergo key fluctuations. If trends hold, the stock might trade between $20.91 and $30.07, averaging $25.65. This signals a cautious trajectory with potential returns around -35.88%.
March 2025
According to our latest forecast models, Calliditas Therapeutics AB (publ) (CALT) is positioned to show a strong performance in March 2025. The price is predicted to move between $21.57 and $32.51, settling at an average of $25.57. This could translate to a -36.08% loss.
April 2025
Based on current market signals, Calliditas Therapeutics AB (publ) is projected to trend april 2025. We forecast a trading range from $26.57 to $33.78, with a likely average price of $30.28. Investors could expect a potential return of -24.30%.
May 2025
Our predictive algorithms indicate Calliditas Therapeutics AB (publ) stock may see a shift in May 2025. The expected range spans $26.24–$32.84, with an average target of $29.80. This represents a cautious outlook and a possible loss of -25.50%.
June 2025
Analyzing established trends, Calliditas Therapeutics AB (publ) looks set to move in June 2025. Projections place the stock between $25.65 and $31.82, averaging around $28.69. This suggests a -28.28% loss from current levels.
July 2025
Market indicators suggest Calliditas Therapeutics AB (publ) could experience notable changes during July 2025. Prices could fluctuate within $22.16 to $31.15, with a midpoint forecast of $26.83. The stock might deliver a -32.93% loss.
August 2025
Forecasting for August 2025, models estimate that Calliditas Therapeutics AB (publ) may undergo key fluctuations. If trends hold, the stock might trade between $22.63 and $34.28, averaging $27.37. This signals a cautious trajectory with potential returns around -31.58%.
September 2025
According to our latest forecast models, Calliditas Therapeutics AB (publ) (CALT) is positioned to show a strong performance in September 2025. The price is predicted to move between $28.10 and $35.01, settling at an average of $31.74. This could translate to a -20.65% loss.
CALT's history of dividends and stock splits also plays a role in long-term investor confidence.